首页> BMC cancer> Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.

Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.

导出 OA

翻译打印收藏纠错

第一作者： Jianye,Liang

第一单位： Department of Medical Imaging, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.

作者： Jianye,Liang ^[1] ; Wei,Dai ^[1] ; Zhipeng,Li ^[1] ; Xiangjing,Liang ^[2] ; Mingjia,Xiao ^[3] ; Chuanmiao,Xie ^[4] ; Xinming,Li ^[5]

作者单位： Department of Medical Imaging, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. ^[1] Ultrasound Medical Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[2] Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[3] Department of Medical Imaging, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. xiechm@sysucc.org.cn. ^[4] Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. lixinmingsmu@163.com. ^[5]

关键词 Endostar Gastric cancer HER2 HLX02 IVIM-DWI Vascular normalization